MedTrace Logo

UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study

NCT03284307 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2023-04-13

Study results available
· View outcomes & findings →

Summary

This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.

Conditions

  • Unconsciousness
  • Consciousness

Interventions

DRUG

Dexmedetomidine

20 participants will be administered Dexmedetomidine.

DRUG

Ketamine

20 participants will be administered Ketamine.

DRUG

Propofol

20 participants will be administered Propofol.

DRUG

Midazolam

20 participants will be administered Midazolam.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Robert A Pearce, MD, PhD · Professor and chair of Anesthesiology at UW- Madison

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-10
Primary Completion
2020-03-12
Completion
2020-03-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284307 on ClinicalTrials.gov